Patents by Inventor Adriana Kruisbeek

Adriana Kruisbeek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
    Publication number: 20210346479
    Abstract: The invention is in the field of medical sciences. It provides means and methods for the treatment of cancer. More in particular, it provides cells and cell lines that can be developed into fully functional dendritic cells. These cells endogenously express cancer-specific antigens, which makes them particularly suited for the treatment of different kinds of cancer. More in particular, the invention relates to a precursor cell line for dendritic cells called DC-One as deposited at the DSMZ under accession number DSMZ ACC3189 on Nov. 15, 2012.
    Type: Application
    Filed: April 23, 2021
    Publication date: November 11, 2021
    Inventors: Sandra Van Wetering, Adriana Kruisbeek
  • Therapeutic cancer vaccines derived from a novel dendritic cell line
    Patent number: 11027001
    Abstract: The invention is in the field of medical sciences. It provides means and methods for the treatment of cancer. More in particular, it provides cells and cell lines that can be developed into fully functional dendritic cells. These cells endogenously express cancer-specific antigens, which makes them particularly suited for the treatment of different kinds of cancer. More in particular, the invention relates to a precursor cell line for dendritic cells called DC-One as deposited at the DSMZ under accession number DSMZ ACC3189 on Nov. 15, 2012.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: June 8, 2021
    Assignee: DCPRIME B.V.
    Inventors: Sandra Van Wetering, Adriana Kruisbeek
  • THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
    Publication number: 20190000945
    Abstract: The invention is in the field of medical sciences. It provides means and methods for the treatment of cancer. More in particular, it provides cells and cell lines that can be developed into fully functional dendritic cells. These cells endogenously express cancer-specific antigens, which makes them particularly suited for the treatment of different kinds of cancer. More in particular, the invention relates to a precursor cell line for dendritic cells called DC-One as deposited at the DSMZ under accession number DSMZ ACC3189 on Nov. 15, 2012.
    Type: Application
    Filed: August 10, 2018
    Publication date: January 3, 2019
    Inventors: Sandra Van Wetering, Adriana Kruisbeek